Sun Pharmaceutical Industries Ltd posted a consolidated net loss of Rs 425 crore in the quarter ending June 2017 as against Rs 2,034 crore in year-ago period.
Consolidated total income decreased 24% to Rs 6,361 crore as compared to Rs 8,413 crore in June 2016.